Recursion Pharmaceuticals Company
Recursion Pharmaceuticals is a digital biology company, developing a drug discovery platform and pipeline with machine learning.
Investors
Connections from
Funding Status:
IPO
Industry:
Medical BioTech
Estimated Revenue:
$10M to $50M
Technology:
['BioTech & HealthTech']
Headquarters:
Salt Lake City, Utah, United States
Total Funding:
665376000
Last Funding Date:
2023-07-12
Last Funding Type:
Post-IPO Equity
Employee Number:
251-500
Investors Number:
35
Founded Date:
2013-11-05